Investment
Features
FeesSafety
Academy
More
Pluang+

Higher interest rates could boost regional banks; KRE ETF offers diversified exposure to benefit.

Market News
18 Jul 2026
24/7 Wall Street
View Source
Bullish
Higher interest rates could boost regional banks; KRE ETF offers diversified exposure to benefit.

With inflation concerns persisting and a hawkish Fed chair, interest rate hikes seem likely. Regional banks, which earn from the spread between loan interest and deposit costs, could benefit from higher rates through increased net interest income and wider margins. The SPDR S&P Regional Banking ETF (KRE) provides diversified exposure to these banks, making it a potential investment to capitalize on a rising rate environment. While risks like rising deposit costs and credit quality remain, stable loan demand could support regional bank profitability and make KRE attractive.

More News

Analysts rate BlackRock stock 'Overweight' ahead of strong Q3 earnings forecast.

Analysts rate BlackRock stock 'Overweight' ahead of strong Q3 earnings forecast.

Wells Fargo initiated coverage on BlackRock with an 'Overweight' rating, highlighting it as a good entry point for investors. Analysts expect BlackRock's Q3 earnings per share to rise to $14.25 from $11.55 a year ago, with revenue projected at $7.56 ...

Analyst Insights
Bullish
1 hour ago
Nike misses revenue targets and issues weak outlook due to China market challenges, shares fall 5.8%.

Nike misses revenue targets and issues weak outlook due to China market challenges, shares fall 5.8%.

Nike reported earnings per share of $0.48, beating estimates, but revenue fell short at $11.21 billion due to weak demand in Greater China and rising competition. The company issued a cautious fiscal 2027 outlook with EPS forecast between $1.15 and $...

Company Fundamentals
Bearish
1 hour ago
NETSOL Technologies posts record Q4 revenue, forecasts strong growth for fiscal 2027.

NETSOL Technologies posts record Q4 revenue, forecasts strong growth for fiscal 2027.

NETSOL Technologies reported a record $20.7 million revenue in fiscal 2026 Q4, with net income rising 45.9% to $3.8 million. The company improved its gross margin to 63.6% and operating margin to 21.6%, reflecting enhanced profitability. For fiscal 2...

Company Fundamentals
Bullish
1 hour ago
Nexalin, Armada, Roze AI, Mattel, and Accenture lead market gains on key deals and earnings beats

Nexalin, Armada, Roze AI, Mattel, and Accenture lead market gains on key deals and earnings beats

On October 1, 2026, Nexalin Technology surged 76.4% after securing a 10-year exclusive deal for its medical device in South America. Armada Acquisition Corp. II jumped 42.9% following shareholder approval of its merger with Evernorth, expected to clo...

Market News
Bullish
1 hour ago
Jefferies sets $150 target for Nektar Therapeutics amid promising alopecia drug data despite stock drop.

Jefferies sets $150 target for Nektar Therapeutics amid promising alopecia drug data despite stock drop.

Jefferies analyst Roger Song set a $150 price target for Nektar Therapeutics, suggesting a 219% upside from its $46.99 trading price. This comes after Nektar presented positive six-month Phase IIb trial results for its alopecia drug REZPEG, which als...

Analyst Insights
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App